Braveheart Bio, Inc. (BRVE)

29.20 +1.49 (+5.38%) USD  |  NASDAQ  |  Sep 18, 16:00
28.95 -0.25 (-0.86%) After-Hours: 20:00
More

Braveheart Bio EPS Diluted (Quarterly) : -0.2066 for June 30, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for BRVE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 -0.2066
March 31, 2026 -0.1586
Date Value
June 30, 2025 -0.0042
March 31, 2025 -0.0011

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Bristol Myers Squibb Co. 1.620
ANI Pharmaceuticals, Inc. 1.052
Corcept Therapeutics, Inc. 0.356
Veru, Inc. -0.3032
IGC Pharma, Inc. -0.0293

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -14.99M
Total Expenses (Quarterly) 14.99M
Enterprise Value 2.720B
Earnings Yield -1.27%
Normalized Earnings Yield -1.264